Search research articles
Contact Us
Filters
Showing results (41-50 of 329) with videos related to
Page
of 33
Sort By:
Journal of the Neurological Sciences
|
March 11, 2009
VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
Roberto Del Bo, Serena Ghezzi, Elio Scarpini, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases
Anna M Pietroboni, Annalisa Colombi, Tiziana Carandini, et al.
Journal of Alzheimer'S Disease : JAD
|
September 6, 2011
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder
Chiara Cerami, Alessandra Marcone, Daniela Galimberti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 15, 2009
Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease
Massimiliano Vitali, Eliana Venturelli, Daniela Galimberti, et al.
Journal of Geriatric Psychiatry and Neurology
|
March 30, 2017
Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review
Massimiliano Buoli, Marta Serati, Alice Caldiroli, et al.
Cells
|
August 7, 2021
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
Marianna D'Anca, Chiara Fenoglio, Francesca Romana Buccellato, et al.
Journal of the Neurological Sciences
|
February 28, 2002
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease
Elio Scarpini, Daniela Galimberti, Pierluigi Baron, et al.
Frontiers in Neurology
|
April 1, 2022
Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
Roberta Mancuso, Simone Agostini, Ambra Hernis, et al.
Trends in Immunology
|
May 28, 2017
The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?
Jens Geginat, Moira Paroni, Massimiliano Pagani, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies
Francesca R Buccellato, Marianna D'Anca, Gianluca Martino Tartaglia, et al.
Page
of 33
Search research articles
Search
Showing results (41-50 of 329) with videos related to
Sort By:
Page
of 33
Journal of the Neurological Sciences
|
March 11, 2009
VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
Roberto Del Bo, Serena Ghezzi, Elio Scarpini, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases
Anna M Pietroboni, Annalisa Colombi, Tiziana Carandini, et al.
Journal of Alzheimer'S Disease : JAD
|
September 6, 2011
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder
Chiara Cerami, Alessandra Marcone, Daniela Galimberti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 15, 2009
Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease
Massimiliano Vitali, Eliana Venturelli, Daniela Galimberti, et al.
Journal of Geriatric Psychiatry and Neurology
|
March 30, 2017
Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review
Massimiliano Buoli, Marta Serati, Alice Caldiroli, et al.
Cells
|
August 7, 2021
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
Marianna D'Anca, Chiara Fenoglio, Francesca Romana Buccellato, et al.
Journal of the Neurological Sciences
|
February 28, 2002
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease
Elio Scarpini, Daniela Galimberti, Pierluigi Baron, et al.
Frontiers in Neurology
|
April 1, 2022
Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
Roberta Mancuso, Simone Agostini, Ambra Hernis, et al.
Trends in Immunology
|
May 28, 2017
The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?
Jens Geginat, Moira Paroni, Massimiliano Pagani, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies
Francesca R Buccellato, Marianna D'Anca, Gianluca Martino Tartaglia, et al.
Page
of 33